£145.64

About as cheap as it gets — within 5% of the all-time low it hit 2 months ago.

£146 today · all-time low £143 (Sep 2026) · usually £146

Birkhauser Atypical Antipsychotics (Milestones in Drug Therapy)

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 65 days · 65 data points (no recent data)

Historical
Generating forecast…
£145.68 £142.41 £143.13 £143.84 £144.55 £145.26 £145.98 23 August 2026 08 September 2026 24 September 2026 10 October 2026 26 October 2026
View at Amazon ↗

Price data last checked 26 day(s) ago - will refresh soon

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 65 days • 3 price levels

Days at Price
Current Price
15 days 6 days 44 days · current 0 11 22 33 44 £143 £144 £146 Days at Price

Price Analysis

Most common price: £146 (44 days, 67.7%)

Price range: £143 - £146

Price levels: 3 different prices over 65 days

Description

The introduction of chlorpromazine in 1953, and haloperidol in 1958, into clinical practice dramatically altered the therapy of schizophrenic patients. Although representing by no means a cure for this severe psychiatric ill ness, it allowed, for the first time, to adequately control the severe hallu cinations and delusional beliefs which prevent these patients from leading a more or less independent life. Indeed these antipsychotics (and the many congeners that were to follow) significantly reduced the number ofchronic schizophrenic inpatients in psychiatric clinics all over the world. However soon after their introduction it became clear that, like all other available drugs, antipsychotics were by no means miracle drugs. In fact, two major problems appeared. First, the antipsychotics had very little effect on the so-called negative or defect symptoms, like social isolation, apathy and anhedonia, and secondly virtually all antipsychotics produced a number of side-effects, of which the neurological (often called extra pyramidal) side-effects were the most troublesome. Especially the tardive dyskinesia, which occurred in about 15 to 20% of the patients after pro longed treatment, represented a major problem in the treatment of schizo phrenic patients.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Psychotropic Agents: Part I: Antipsychotics and Antidepressants: 55 / 1 (Handbook of Experimental Pharmacology, 55 / 1)
78% match

Psychotropic Agents: Part I: Antipsychotics and Antidepressants: 55 / 1 (Handbook of Experimental Pharmacology, 55 / 1)

Springer

£109.08 08 Sep 2026
Methodology of the Evaluation of Psychotropic Drugs: 8 (Psychopharmacology Series, 8)
76% match

Methodology of the Evaluation of Psychotropic Drugs: 8 (Psychopharmacology Series, 8)

Springer

£78.01 12 Sep 2026
Anxiolytics (Milestones in Drug Therapy)
76% match

Anxiolytics (Milestones in Drug Therapy)

Birkhauser

£77.90 24 Oct 2026
Clinical Manual for Treatment of Schizophrenia
76% match

Clinical Manual for Treatment of Schizophrenia

American Psychiatric Association Publishing

£50.20 24 Oct 2026
Psychopharmaka bei psychiatrischen Erkrankungen: Neuroleptika, Tranquilizer, Antidepressiva. Anwendungsgrundsätze, Nebenwirkungen, Kontraindikationen, spezielle Hinweise und tabellarische Übersicht
75% match

Psychopharmaka bei psychiatrischen Erkrankungen: Neuroleptika, Tranquilizer, Antidepressiva. Anwendungsgrundsätze, Nebenwirkungen, Kontraindikationen, spezielle Hinweise und tabellarische Übersicht

Vieweg+Teubner Verlag

£57.09 23 Oct 2026
Treatment-Resistant Schizophrenia: Evidence-based Pharmacotherapy, Cognitive Behavioral Psychotherapy and Rehabilitation
74% match

Treatment-Resistant Schizophrenia: Evidence-based Pharmacotherapy, Cognitive Behavioral Psychotherapy and Rehabilitation

Springer

£54.71 20 Oct 2026
APA Publishing Clinical Manual of Geriatric Psychopharmacology
74% match

APA Publishing Clinical Manual of Geriatric Psychopharmacology

American Psychiatric Association Publishing

£63.07 15 Nov 2026
Lithium: Its Role in Psychiatric Research and Treatment
74% match

Lithium: Its Role in Psychiatric Research and Treatment

Springer

£78.01 26 Oct 2026
The Neuropsychology Of Schizophrenia (Brain, Behaviour and Cognition)
73% match

The Neuropsychology Of Schizophrenia (Brain, Behaviour and Cognition)

Psychology Press

£52.76 03 Nov 2026
Handbook of Neurochemistry and Molecular Neurobiology: Schizophrenia (Springer Reference)
73% match

Handbook of Neurochemistry and Molecular Neurobiology: Schizophrenia (Springer Reference)

Springer

£113.73 24 Oct 2026
The Medical Basis of Psychiatry
73% match

The Medical Basis of Psychiatry

Humana

£148.19 23 Oct 2026
Animal Models of Schizophrenia and Related Disorders: 59 (Neuromethods, 59)
73% match

Animal Models of Schizophrenia and Related Disorders: 59 (Neuromethods, 59)

Humana

£95.74 24 Oct 2026
Anxiety Disorders: Pathophysiology and Pharmacological Treatment
73% match

Anxiety Disorders: Pathophysiology and Pharmacological Treatment

Birkhauser

£76.42 23 Oct 2026
Stahl's Antipsychotic Plasma Levels - Cambridge University Press
73% match

Stahl's Antipsychotic Plasma Levels - Cambridge University Press

Cambridge University Press

£40.47 31 Oct 2026
Schizophrenia: Breaking Down the Barriers
73% match

Schizophrenia: Breaking Down the Barriers

Wiley

Price unavailable
Affective and Schizoaffective Disorders: Similarities and Differences
72% match

Affective and Schizoaffective Disorders: Similarities and Differences

Springer

£91.03 11 Sep 2026
Neurological and Psychiatric Disorders (Current Clinical Neurology)
72% match

Neurological and Psychiatric Disorders (Current Clinical Neurology)

Humana

£103.27 24 Oct 2026
Psychopharmacology of the Developmental Disabilities (Disorders of Human Learning, Behavior, and Communication)
72% match

Psychopharmacology of the Developmental Disabilities (Disorders of Human Learning, Behavior, and Communication)

Springer

£76.42 24 Oct 2026
Psychotropic Agents: Part III: Alcohol and Psychotomimetics, Psychotropic Effects of Central Acting Drugs: 55 / 3 (Handbook of Experimental Pharmacology, 55 / 3)
72% match

Psychotropic Agents: Part III: Alcohol and Psychotomimetics, Psychotropic Effects of Central Acting Drugs: 55 / 3 (Handbook of Experimental Pharmacology, 55 / 3)

Springer

£113.76 24 Oct 2026
Schizophrenia: Concepts and Clinical Management
72% match

Schizophrenia: Concepts and Clinical Management

Cambridge University Press

£34.58 26 Oct 2026
Behavioral Neurobiology of Schizophrenia and Its Treatment: 4 (Current Topics in Behavioral Neurosciences, 4)
72% match

Behavioral Neurobiology of Schizophrenia and Its Treatment: 4 (Current Topics in Behavioral Neurosciences, 4)

Springer

£148.21 24 Oct 2026
Reconstructing Schizophrenia
72% match

Reconstructing Schizophrenia

Routledge

£39.66 27 Oct 2026
School Psychopharmacology: Translating Research into Practice (Pediatric School Psychology)
72% match

School Psychopharmacology: Translating Research into Practice (Pediatric School Psychology)

Springer

£68.52 26 Oct 2026
Schizophrenia and Psychotic Spectrum Disorders (Primer On)
72% match

Schizophrenia and Psychotic Spectrum Disorders (Primer On)

Oxford University Press

£80.92 22 Oct 2026